Evidence map›Paper›PMID 30799549›Full record

ArticleCardiology journal2020

Anisocytosis predicts postoperative renal replacement therapy in patients undergoing heart valve surgery.

Piotr Duchnowski, Tomasz Hryniewiecki, Mariusz Kuśmierczyk, Piotr Szymański

Open access · goldAbstract read
In one paragraph

Article in Cardiology journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Piotr DuchnowskiDepartment of Acquired Cardiac Defects, Institute of Cardiology, Alpejska 42, Warsaw, Poland. duchnowski@vp.pl.
Tomasz HryniewieckiDepartment of Acquired Cardiac Defects, Institute of Cardiology, Alpejska 42, Warsaw, Poland.
Mariusz KuśmierczykDepartment of Acquired Cardiac Defects, Institute of Cardiology, Alpejska 42, Warsaw, Poland.
Piotr SzymańskiDepartment of Acquired Cardiac Defects, Institute of Cardiology, Alpejska 42, Warsaw, Poland.
Institute of Cardiology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute kidney injury (AKI) is one of the serious postoperative complications in patients undergoing heart valve surgery. The aim of the present study was to identify selected biomarkers to predict AKI requiring renal replacement.

methodsA prospective study was conducted on a group of 751 patients undergoing heart valve surgery. The data on risk factors, preoperative complete blood count, course of operations and postoperative period was assessed. The primary endpoint at the 30-day follow-up was postoperative AKI requiring renal replacement therapy. The secondary end-point was death from all causes in patients with postoperative AKI requiring renal replacement.

resultsThe primary endpoint occurred in 46 patients. At multivariate analysis: age, red cell distribution width (RDW) and C-reactive protein remained independent predictors of the primary endpoint. Hemoglobin and RDW were associated with an increased risk of death.

conclusionsElevated RDW is associated with a higher risk of postoperative AKI and death in patients with AKI.

Indexed as

Cardiac Surgical ProceduresRenal Replacement TherapyHeart ValvesHumansPostoperative ComplicationsPostoperative PeriodProspective StudiesRisk Factorsacute kidney injuryanisocytosisred cell distribution widthvalve surgery

Identifiers

PMID30799549
PMCPMC8016011
OpenAlexW2917217828

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.